We are live on ! Find out more
KIDS icon

OrthoPediatrics

120 hedge funds and large institutions have $317M invested in OrthoPediatrics in 2026 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 52 increasing their positions, 32 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% more repeat investments, than reductions

Existing positions increased: 52 | Existing positions reduced: 32

22% more capital invested

Capital invested by funds: $259M → $317M (+$57.7M)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

0.09% less ownership

Funds ownership: 64.52%64.43% (-0.09%)

1% less funds holding

Funds holding: 121120 (-1)

Holders
120
Holders Change
-1
Holders Change %
-0.83%
% of All Funds
1.44%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
52
Reduced
32
Closed
17
Calls
$2K
Puts
Net Calls
+$2K
Net Calls Change
-$144K

KIDS Hedge Fund Activity: Q2 2026 in Review

120 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in OrthoPediatrics (KIDS) for Q2 2026, worth a combined $317M — up 22% from $259M a quarter earlier.

Fund positioning in KIDS was balanced in Q2 2026: 17 funds opened new positions, 17 closed out, 52 added to existing stakes and 32 trimmed.

The largest buyer was AIGH Capital Management, opening a new position worth an estimated $4.69M. The largest seller was Morgan Stanley, cutting an estimated $7.78M.

  • 120 institutional investors held OrthoPediatrics (KIDS) as of Q2 2026, down from 121 in Q1 2026.
  • Funds reported $317M of OrthoPediatrics stock for Q2 2026, up 22% quarter-over-quarter.
  • 17 funds opened new OrthoPediatrics positions in Q2 2026 and 17 closed out, a net change of 0 holders.
  • The largest OrthoPediatrics buyer in Q2 2026 was AIGH Capital Management, an estimated $4.69M added.
  • The largest OrthoPediatrics seller in Q2 2026 was Morgan Stanley, an estimated $7.78M sold.

Based on aggregated 13F filings for Q2 2026.